-
Location
-
Roivant Sciences, Inc., 151 W. 42 Nd St., 15 Th Floor, New York, NY
-
Summary
-
The estimated net worth of Matthew Gline is at least $318M dollars as of May 22, 2025. Matthew Gline is the CEO, Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $191M. Matthew Gline is the Director, 10%+ Owner of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $128M.
-
Signature
-
By: /s/ Jo Chen, as Attorney-in-Fact for Matthew Gline